These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18643858)

  • 1. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population.
    Sakakibara R; Uchiyama T; Yamanishi T; Kishi M
    Int J Urol; 2008 Sep; 15(9):778-88. PubMed ID: 18643858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
    Gill SS; Mamdani M; Naglie G; Streiner DL; Bronskill SE; Kopp A; Shulman KI; Lee PE; Rochon PA
    Arch Intern Med; 2005 Apr; 165(7):808-13. PubMed ID: 15824303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic effects of medication in elderly patients.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():11-4. PubMed ID: 11584981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary incontinence in dementia - a practical approach.
    Yap P; Tan D
    Aust Fam Physician; 2006 Apr; 35(4):237-41. PubMed ID: 16642241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.
    Siegler EL; Reidenberg M
    Clin Pharmacol Ther; 2004 May; 75(5):484-8. PubMed ID: 15116061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy.
    Minaglia S; Ozel B; Bizhang R; Mishell DR
    Urology; 2005 Oct; 66(4):702-6. PubMed ID: 16230120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology and predictors of urinary incontinence and its effect on quality of life.
    Miu DK; Lau S; Szeto SS
    Geriatr Gerontol Int; 2010 Apr; 10(2):177-82. PubMed ID: 20446932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-surgical treatment for detrusor overactivity.
    Slack RA; Jackson S
    J Br Menopause Soc; 2006 Sep; 12(3):109-14. PubMed ID: 16953984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary incontinence: anticholinergic treatment].
    Jimenez Cidre MA
    Rev Med Univ Navarra; 2004; 48(4):37-42. PubMed ID: 15810718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary incontinence associated with dementia.
    Skelly J; Flint AJ
    J Am Geriatr Soc; 1995 Mar; 43(3):286-94. PubMed ID: 7884121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary incontinence and senile dementia. The relationship between the severity of dementia and the potential for treatment of the urinary incontinence].
    de Fockert JA
    Tijdschr Gerontol Geriatr; 1989 Jun; 20(3):101-6. PubMed ID: 2749864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of overactive bladder (OBA) with anti-cholinergic drugs and the risk of glaucoma.
    Eskandar OS; Eckford SD; Whittaker KW
    J Obstet Gynaecol; 2005 Jul; 25(5):419-21. PubMed ID: 16183571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.
    Sakakibara R; Ogata T; Uchiyama T; Kishi M; Ogawa E; Isaka S; Yuasa J; Yamamoto T; Ito T; Yamanishi T; Awa Y; Yamaguchi C; Takahashi O
    J Am Geriatr Soc; 2009 Aug; 57(8):1515-7. PubMed ID: 19682155
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
    Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
    Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial of emepronium bromide for the treatment of urinary incontinence in the elderly mentally ill.
    Williams AJ; Prematalake JK; Palmer RL
    Pharmatherapeutica; 1981; 2(8):539-42. PubMed ID: 7019932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of anticholinergic medication use in elderly dementia patients.
    Sura SD; Carnahan RM; Chen H; Aparasu RR
    Drugs Aging; 2013 Oct; 30(10):837-44. PubMed ID: 23881698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticholinergic treatment of overactive bladder. A costly treatment with doubtful clinical effect?].
    Møller LA; Lose G
    Ugeskr Laeger; 2003 Nov; 165(47):4552-3. PubMed ID: 14677238
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
    Schmid DM; Roy S; Sulser T; Scheiner D
    BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.